Suppr超能文献

在一个多代家庭中进行重复外显子组测序:改进对下一代测序数据的解读。

Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.

作者信息

Cherukuri Praveen F, Maduro Valerie, Fuentes-Fajardo Karin V, Lam Kevin, Adams David R, Tifft Cynthia J, Mullikin James C, Gahl William A, Boerkoel Cornelius F

机构信息

NIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH, Bethesda, MD, USA.

Inova Translational Medicine Institute, Inova Health System, Falls Church, VA, USA.

出版信息

BMC Genomics. 2015 Nov 25;16:998. doi: 10.1186/s12864-015-2107-y.

Abstract

BACKGROUND

Whole-exome sequencing (WES) is rapidly evolving into a tool of choice for rapid, and inexpensive identification of molecular genetic lesions within targeted regions of the human genome. While biases in WES coverage of nucleotides in targeted regions are recognized, it is not well understood how repetition of WES improves the interpretation of sequencing results in a clinical diagnostic setting.

METHOD

To address this, we compared independently generated exome-capture of six individuals from three-generations sequenced in triplicate. This generated between 48x-86x mean target depth of high-quality mapped bases (>Q20) for each technical replicate library. Cumulatively, we achieved 179 - 208x average target coverage for each individual in the pedigree. Using this experimental design, we evaluated stochastics in WES interpretation, genotyping sensitivity, and accuracy to detect de novo variants.

RESULTS

In this study, we show that repetition of WES improved the interpretation of the capture target regions after aggregating the data (93.5 - 93.9 %). Compared to 81.2 - 89.6 % (50.2-55.4 Mb of 61.7 M) coverage of targeted bases at ≥20x in the individual technical replicates, the aggregated data covered 93.5 - 93.9 % of targeted bases (57.7 - 58.0 of 61.7 M) at ≥20x threshold, suggesting a 4.3 - 12.7 % improvement in coverage. Each individual's aggregate dataset recovered 3.4 - 6.4 million bases within variable targeted regions. We uncovered technical variability (2-5 %) inherent to WES technique. We also show improved interpretation in assessing clinically important regions that lack interpretation under current conditions, affecting 12-16 of the 56 genes recommended for secondary analysis by American College of Medical Genetics (ACMG). We demonstrate that comparing technical replicate WES datasets and their derived aggregate data can effectively address overall WES genotyping discrepancies.

CONCLUSION

We describe a method to evaluate the reproducibility and stochastics in exome library preparation, and delineate the advantages of aggregating the data derived from technical replicates. The implications of this study are directly applicable to improved experimental design and provide an opportunity to rapidly, efficiently, and accurately arrive at reliable candidate nucleotide variants.

摘要

背景

全外显子组测序(WES)正在迅速发展成为一种用于快速且廉价地识别人类基因组靶向区域内分子遗传损伤的首选工具。虽然人们已经认识到WES在靶向区域核苷酸覆盖方面存在偏差,但对于在临床诊断环境中重复进行WES如何改善测序结果的解读,目前还了解得不够透彻。

方法

为了解决这个问题,我们比较了对来自三代的6个人独立进行三次测序的外显子捕获结果。每个技术重复文库的高质量比对碱基(>Q20)平均目标深度在48x - 86x之间。累积起来,我们对家系中的每个个体实现了179 - 208x的平均目标覆盖度。利用这个实验设计,我们评估了WES解读中的随机性、基因分型敏感性以及检测新生变异的准确性。

结果

在本研究中,我们表明在汇总数据后,重复进行WES可改善捕获目标区域的解读(93.5 - 93.9%)。与单个技术重复中≥20x时靶向碱基81.2 - 89.6%(6170万个碱基中的5020 - 5540万个)的覆盖度相比,汇总数据在≥20x阈值时覆盖了93.5 - 93.9%的靶向碱基(6170万个碱基中的5770 - 5800万个), 表明覆盖度提高了4.3 - 12.7%。每个个体的汇总数据集在可变靶向区域内找回了340 - 640万个碱基。我们发现了WES技术固有的技术变异性(2 - 5%)。我们还表明,在评估当前条件下缺乏解读的临床重要区域时,解读得到了改善,这影响了美国医学遗传学学会(ACMG)推荐进行二次分析的56个基因中的12 - 16个。我们证明,比较技术重复的WES数据集及其衍生的汇总数据可以有效地解决整体WES基因分型差异。

结论

我们描述了一种评估外显子文库制备中可重复性和随机性的方法,并阐述了汇总技术重复数据的优势。本研究的意义直接适用于改进实验设计,并提供了一个快速、高效且准确地得出可靠候选核苷酸变异的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2037/4659195/135d56e57efc/12864_2015_2107_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验